CLA (Conjugated Linoleic Acid): The Complete Supplement Guide

Quick Reference Card

Overview

The Basics

CLA stands for conjugated linoleic acid, a group of fatty acids found naturally in small amounts in meat and dairy products from grass-fed ruminant animals like cows, sheep, and goats [1]. The word "conjugated" refers to the arrangement of the double bonds in the fatty acid chain, which sit next to each other rather than being separated, as they are in regular linoleic acid.

There are actually 28 different forms (called isomers) of CLA, but only two matter for supplementation purposes: one called c9,t11 (the form that makes up over 90% of the CLA in food) and another called t10,c12 [1][2]. These two isomers do different things in the body. The t10,c12 form is primarily associated with body composition effects, while the c9,t11 form has been studied more for its potential role in cancer prevention [2].

CLA became popular as a weight loss supplement after animal studies showed dramatic reductions in body fat. In mice and rats, CLA supplementation produced impressive fat loss results. The jump to humans, however, has been disappointing. Multiple meta-analyses of human trials consistently find that CLA's effects on body fat are statistically detectable but very small, on the order of losing an extra 0.2 pounds per week, which is difficult to notice outside of a controlled laboratory setting [3][4][5].

Most commercial CLA supplements are made synthetically from safflower or sunflower oil through a chemical process called alkaline isomerization, which produces a roughly 50:50 mix of the two main isomers [1]. This differs substantially from the CLA found naturally in food, where the c9,t11 isomer predominates.

The Science

Conjugated linoleic acids (CLAs) are a family of positional and geometric isomers of linoleic acid (C18:2 n-6) characterized by conjugated double bonds, meaning the double bonds are separated by a single carbon-carbon bond rather than the methylene group that separates them in standard linoleic acid [1][2]. Of the 28 identified isomers, cis-9,trans-11 (c9,t11; also known as rumenic acid) and trans-10,cis-12 (t10,c12) are the most extensively studied and the primary constituents of commercial supplements [1].

In ruminant-derived foods, CLA originates from two pathways: (1) incomplete biohydrogenation of linoleic acid by rumen bacteria (Butyrivibrio fibrisolvens), which produces c9,t11-CLA as an intermediate, and (2) endogenous synthesis via delta-9-desaturase (stearoyl-CoA desaturase, SCD) from vaccenic acid (trans-11 C18:1), another biohydrogenation intermediate [1]. The endogenous pathway accounts for 70-95% of c9,t11-CLA in milk fat.

Dietary CLA intake from food sources has been estimated at 212 mg/day for adult men and 151 mg/day for adult women, with dairy products contributing the majority [1]. Supplemental CLA is produced synthetically via heat alkaline isomerization of linoleic acid (typically from safflower or sunflower oil), yielding a mixture where c9,t11 and t10,c12 constitute approximately 80% of total isomers in a roughly 1:1 ratio [1].

CLA isomers undergo metabolism similar to linoleic acid, including elongation and desaturation to produce conjugated 18:3, conjugated 20:3, and conjugated arachidonic acid (conjugated 20:4) analogs, retaining the conjugated diene structure throughout [1]. These metabolites are incorporated into cell membrane phospholipids, with conjugated 20:4 preferentially incorporated into phosphatidylinositol and phosphatidylserine [1].

Chemical & Nutritional Identity

Regulatory Reference Values:

No RDA, AI, or UL has been established for CLA by the Institute of Medicine (IOM) or EFSA. CLA is not classified as an essential nutrient.

Estimated Dietary Intake:

Common Supplement Forms

Mechanism of Action

The Basics

CLA works through several pathways in the body, but the central mechanism involves activating a family of cellular receptors called PPARs (peroxisome proliferator-activated receptors). Think of PPARs as switches inside your cells that control how the body handles fat storage, burns energy, and manages inflammation [2][6].

When CLA reaches your cells, it can flip these PPAR switches, particularly PPARgamma and PPARalpha. In theory, this should speed up the rate at which your body breaks down stored fat and slow down the rate at which it creates new fat cells. This is exactly what happens in mice and rats, where the effects are dramatic [2][6]. In humans, however, CLA's interaction with these receptors appears to be much weaker, which helps explain why the fat loss results in people are so much smaller than in animals [2].

The two main CLA isomers have distinct roles. The t10,c12 isomer is the one primarily responsible for body composition effects. It works by inhibiting an enzyme called stearoyl-CoA desaturase (SCD), which is involved in fat production, and by competing with arachidonic acid for enzymes that produce inflammatory molecules [2][7]. The c9,t11 isomer, which is the form found most abundantly in food, has been studied more for potential anticancer effects, partly through its ability to influence cell growth regulators [2].

CLA also affects prostaglandin production. Prostaglandins are hormone-like molecules that help regulate inflammation, blood clotting, and other processes. CLA reduces the production of certain pro-inflammatory prostaglandins, particularly PGE2 [7]. This sounds beneficial, but the overall inflammatory picture with CLA is complicated: some markers of inflammation go down while others go up.

The Science

CLA isomers exert biological effects through multiple molecular mechanisms, with isomer-specific actions being a critical distinguishing feature of this compound class [2][6][7].

PPAR activation: Both c9,t11 and t10,c12 CLA isomers serve as ligands for peroxisome proliferator-activated receptors (PPARalpha, PPARgamma, and PPARdelta). PPARgamma activation in adipose tissue has been implicated in CLA-mediated reduction of adiposity in animal models, potentially through promotion of adipocyte apoptosis and inhibition of preadipocyte differentiation [6]. However, the binding affinity of CLA isomers for human PPAR receptors is substantially lower than that of pharmaceutical PPAR agonists such as thiazolidinediones, which partially explains the attenuated effects observed in human studies [2].

Stearoyl-CoA desaturase (SCD) inhibition: The t10,c12 isomer inhibits SCD-1 (delta-9-desaturase) activity, reducing the conversion of saturated fatty acids to monounsaturated fatty acids. SCD inhibition affects membrane lipid composition and has downstream consequences for lipogenesis and energy metabolism [2][7].

Eicosanoid pathway modulation: CLA competes with arachidonic acid (AA; C20:4n-6) as a substrate for cyclooxygenase (COX) and lipoxygenase (LOX) enzymes. CLA reduces prostaglandin E2 (PGE2) synthesis and may produce conjugated arachidonic acid analogs (conjugated 20:4) that compete with standard eicosanoids [1][7]. CLA metabolites are preferentially incorporated into phosphatidylinositol and phosphatidylserine in cell membranes [1].

Insulin signaling: The t10,c12 isomer has been shown to decrease insulin sensitivity in obese men with metabolic syndrome, an effect attributed to increased lipid peroxidation and oxidative stress in adipose tissue [8]. This isomer also reduces insulin-like growth factor-II (IGF-II) secretion at both transcriptional and post-transcriptional levels [7].

Adipocyte effects: In animal models, CLA reduces abdominal adiposity through increased energy expenditure and enhanced fatty acid oxidation. Proposed mechanisms include increased lipolysis, reduced lipogenesis, and promotion of apoptosis in adipose tissue [3][6]. In human skeletal muscle, CLA has been shown to enhance the rate of glycogen resynthesis after exercise [9].

NF-kB signaling: CLA modulates nuclear factor-kappa B (NF-kB) signaling pathways, contributing to its mixed inflammatory profile. This pathway influence partially explains why CLA can simultaneously decrease some inflammatory markers (TNF-alpha, IL-6) while increasing others (CRP) [10][11].

Absorption & Bioavailability

The Basics

CLA is absorbed in the small intestine in a similar manner to other dietary fats. Taking CLA with food, particularly meals containing some fat, generally improves absorption and helps reduce the gastrointestinal discomfort that some people experience [2].

The form of CLA supplement matters somewhat for absorption. CLA is available as either a free fatty acid (FFA) or bound to a glycerol backbone as a triacylglycerol (TAG). One clinical trial found that the FFA form produced a slightly greater reduction in body fat mass compared to the TAG form, although both were effective [3]. However, differences in absorption between these two forms are relatively modest compared to the overall small effect size of CLA itself.

Once absorbed, CLA isomers are incorporated into cell membranes and body tissues. The c9,t11 isomer tends to accumulate more readily in tissues than the t10,c12 isomer. Studies measuring CLA incorporation into peripheral blood mononuclear cells (PBMCs) have shown significant increases in tissue CLA concentrations following supplementation [1].

Unlike many fat-soluble supplements, CLA does not have well-characterized storage patterns or half-life data in humans. The body processes CLA through the same elongation and desaturation pathways used for regular linoleic acid [1].

The Science

CLA absorption follows the general pathway for long-chain fatty acids, involving micellar solubilization in the intestinal lumen, uptake by enterocytes, re-esterification into triacylglycerols, incorporation into chylomicrons, and delivery via the lymphatic system to systemic circulation [1].

Bioavailability comparisons between the free fatty acid (FFA) and triacylglycerol (TAG) forms of CLA supplements have yielded modest differences. In the Blankson et al. (2000) trial, the FFA form (3.6 g CLA isomers) produced a 6.9% reduction in body fat mass from baseline, compared with the TAG form (3.0 g CLA isomers), though the lower dose in the TAG arm complicates direct comparison [3].

Following absorption, CLA isomers are metabolized through elongation and desaturation reactions analogous to linoleic acid metabolism, producing conjugated 18:3, conjugated 20:3, and conjugated arachidonic acid (conjugated 20:4) analogs while retaining the conjugated diene structure [1]. Tissue incorporation studies demonstrate that CLA and its metabolites are preferentially deposited in adipose and mammary tissues (incorporated into neutral lipids) and in specific phospholipids (phosphatidylinositol and phosphatidylserine) in other tissues [1].

CLA metabolites content in adipose and mammary tissues ranges from 5-15% of total CLA content. The metabolic interference with linoleic acid pathways, particularly the reduction in arachidonic acid availability, represents a key pharmacological consequence of CLA supplementation [1].

Safflower oil consumption does not increase plasma CLA concentrations, confirming that dietary linoleic acid is not significantly converted to CLA in human tissues and that supplemental or ruminant-derived CLA is required to increase tissue levels [12].

Research & Clinical Evidence

The Basics

CLA has been extensively studied, primarily for body composition effects, but also for potential roles in cardiovascular health, cancer prevention, and immune function. The overall picture from human research is one of modest, often inconsistent effects [2][3][4][5].

Body composition: This is the area with the most research. Multiple meta-analyses have examined whether CLA helps people lose fat. The consistent finding is that CLA produces a small, statistically significant reduction in body fat, roughly 0.2 pounds per week at doses around 3.2 g/day. However, several analyses note that when only high-quality studies are considered, even these small effects disappear [4][5]. CLA may also produce a very small increase in fat-free mass (about 0.27 kg on average) [4].

Cardiovascular health: The evidence here is concerning rather than encouraging. While CLA may modestly reduce body weight and BMI in people at cardiovascular risk, it has no beneficial effect on blood lipids or blood pressure [5]. More worryingly, CLA supplementation has been found to increase lipoprotein(a), an independent risk factor for heart disease [13]. Some studies also show CLA can increase the total-to-HDL cholesterol ratio and reduce beneficial HDL cholesterol levels [7][14].

Cancer prevention: Animal and cell studies have shown promising anticancer effects, particularly for colorectal and breast cancer. However, a meta-analysis of human data found no association between CLA intake and reduced breast cancer risk [7]. This remains an area where the animal evidence has not translated to humans.

Inflammation: CLA's effects on inflammation are contradictory. A large meta-analysis found that CLA supplementation decreases TNF-alpha and IL-6 (anti-inflammatory) but increases C-reactive protein (pro-inflammatory) [10][11]. This dual profile makes it difficult to characterize CLA as either anti-inflammatory or pro-inflammatory overall.

The Science

Body composition meta-analyses: Whigham et al. (2007) conducted a meta-analysis finding CLA at 3.2 g/day produced fat mass reduction of approximately 0.09 kg/week compared to placebo [15]. Asbaghi et al. (2023) performed an updated dose-response meta-analysis of RCTs finding small but significant decreases in body mass and BMI, with increased FFM (WMD: 0.27 kg, 95% CI: 0.09-0.45, P = 0.003). Critically, high-quality study subgroup analysis failed to confirm CLA's body fat-lowering properties [4]. Esmaeilnejad et al. (2024), in a GRADE-assessed meta-analysis of 14 RCTs (17 effect sizes), found CLA supplementation reduced body weight (WMD: -0.72 kg, P < 0.001), BMI (WMD: -0.22 kg/m2, P = 0.037), and body fat percentage (WMD: -1.32%, P = 0.005) in CVD-risk patients [5].

Lipid profile effects: A meta-analysis of 6 RCTs (752 subjects) by Leilami et al. (2021) found CLA supplementation significantly increased circulating lipoprotein(a) levels (WMD: 16.68 mg/L, 95% CI: 5.43-27.93), particularly at doses >=3.5 g/day and in overweight/obese individuals [13]. A separate meta-analysis of 35 RCTs found CLA raised triglycerides compared to olive oil controls while decreasing total cholesterol compared to placebo [14]. Wanders et al. (2010) reported that high CLA intake decreased HDL cholesterol levels [7].

Inflammatory markers: Rastgoo et al. (2023) conducted a GRADE-assessed meta-analysis of 42 studies (58 arms) finding CLA supplementation significantly decreased IL-6 and TNF-alpha but slightly increased CRP levels. Subgroup analysis found CLA reduced adiponectin and leptin in women specifically [10]. Haghighatdoost et al. (2018) confirmed the proinflammatory CRP increase in a separate meta-analysis [11].

Glycemic effects: A GRADE-assessed meta-analysis of 13 RCTs found CLA supplementation led to significant increases in fasting blood glucose and AST (a liver enzyme), alongside favorable effects on IL-6 and leptin [16]. Riserus et al. (2004) demonstrated that c9,t11-CLA supplementation decreased insulin sensitivity in obese men at high risk for cardiovascular disease [8].

Cancer evidence: In vitro studies show CLA inhibits breast cancer cell (MCF-7) proliferation through isomer-specific mechanisms [7]. In animal models of colorectal cancer, CLA reduced disease activity through PPARgamma activation and enhanced caspase-3 mediated apoptosis [7]. Preliminary human studies in rectal cancer suggest CLA may improve inflammatory markers and reduce angiogenesis via MMP-9 inhibition [7]. However, a meta-analysis of observational studies found no association between CLA intake and breast cancer risk [7].

Exercise performance: CLA did not impact aerobic capacity, aerobically-induced neuromuscular fatigue, or exercise performance in controlled trials [7][17]. One study found CLA enhanced glycogen resynthesis in human skeletal muscle after exercise [9].

Evidence & Effectiveness Matrix

Benefits & Potential Effects

The Basics

CLA's benefits are modest at best, and it is important to set realistic expectations. Unlike supplements with strong evidence behind them, CLA sits in a category where the effects are technically real but so small that most people will not notice them in daily life.

The most consistent finding is a very slight reduction in body fat over time. At standard supplemental doses, research suggests you might lose an extra fraction of a pound per week compared to not taking it. Over several months, this could add up to a few pounds of fat loss, but only if everything else in your routine stays consistent. Most people who try CLA report that they cannot distinguish its effects from normal fluctuations in weight [2][3][4].

Some research suggests CLA may help preserve lean muscle mass during weight loss, which is potentially more interesting than the fat loss effect itself. A meta-analysis found a small but statistically significant increase in fat-free mass with CLA supplementation [4].

Beyond body composition, CLA has been explored for possible anticancer effects, primarily based on animal and cell studies. These findings have not convincingly translated to humans, and no health authority recommends CLA for cancer prevention [7].

There is limited evidence suggesting CLA may offer modest benefits for bone health markers in people with rheumatoid arthritis and as an adjunct in mild asthma management [7]. These are preliminary findings from small studies and should not be considered established benefits.

The Science

Body composition: The most robust evidence for CLA supplementation relates to modest effects on body composition. Meta-analytic data from Whigham et al. (2007) established a benchmark of approximately 0.09 kg/week fat mass reduction at 3.2 g/day [15]. Esmaeilnejad et al. (2024) found body weight reduction of -0.72 kg (P < 0.001) and body fat percentage reduction of -1.32% (P = 0.005) in CVD-risk patients [5]. Asbaghi et al. (2023) additionally reported a small increase in fat-free mass (WMD: 0.27 kg, P = 0.003) [4]. The clinical significance of these findings remains contested across all meta-analyses.

Potential anticancer activity: In vitro, c9,t11-CLA induced tissue inhibitor of metalloproteinase (TIMP-1 and TIMP-2) mRNA expression in SGC-7901 gastric carcinoma cells, potentially inhibiting the metastasis cascade [7]. In rectal cancer patients, CLA supplementation improved inflammatory markers and reduced angiogenesis via MMP-9 inhibition [7]. However, a meta-analysis of observational studies found no association between dietary CLA intake and breast cancer risk [7].

Respiratory function: MacRedmond et al. (2010) reported that CLA improved airway hyper-reactivity in overweight mild asthmatics as an adjunct to standard care [18]. Ghobadi et al. (2016, 2018) found that CLA supplementation improved nutritional status and reduced oxidative stress markers in COPD patients [7].

Bone health: Aryaeian et al. (2016) found CLA had useful effects on bone markers in patients with rheumatoid arthritis [7].

Glycogen resynthesis: Tsao et al. (2015) demonstrated that oral CLA supplementation enhanced the rate of glycogen resynthesis in exercised human skeletal muscle [9].

When you're taking multiple supplements, it's hard to know which one is doing the heavy lifting. The benefits described above may overlap with effects from other items in your stack, lifestyle changes, or seasonal variation. Doserly helps you untangle that by keeping everything in one place, with timestamps, doses, and outcomes logged together.

Over time, this builds something more valuable than any product review: your personal evidence record. You can see exactly when you started this supplement, what else was in your routine at the time, and how your tracked health markers responded. That clarity makes the difference between guessing and knowing, whether you're talking to a healthcare provider or simply deciding if it's worth reordering.

Side Effects & Safety

The Basics

CLA is generally considered safe at standard supplemental doses (2.4 to 6 g/day) for up to 12 months, and most people tolerate it without major problems [3]. The most common side effects are digestive issues: stomach discomfort, diarrhea, loose stools, constipation, or indigestion. Taking CLA with meals typically helps reduce these symptoms.

There are a few more significant concerns worth knowing about. First, CLA may negatively affect blood sugar control, particularly in people who are already obese or have metabolic syndrome. One study found that CLA supplementation caused insulin resistance in obese men at high cardiovascular risk [8]. This is an important consideration for anyone with diabetes or prediabetes.

Second, CLA has been associated with unfavorable changes in blood lipid markers. It may lower HDL (the protective cholesterol), increase lipoprotein(a) (an independent heart disease risk factor), and alter the total-to-HDL cholesterol ratio in an unfavorable direction [7][13][14]. These effects are particularly relevant for anyone with existing cardiovascular concerns.

Third, while rare, there are case reports of more serious adverse events: a case of acute hepatitis in a young woman using a CLA supplement for weight loss, migraine visual disturbances triggered by CLA supplementation, and a case of reversible cerebral vasoconstriction syndrome in a woman who started a supplement containing CLA along with green tea and L-carnitine [7].

Fatigue has also been reported as an adverse effect in some studies [7].

The Science

Tolerability profile: A 12-month safety trial (Whigham et al., 2004) found CLA at doses of 2.4-6 g/day was generally safe in obese adults. Gastrointestinal adverse effects (abdominal discomfort, constipation, diarrhea, loose stools, dyspepsia) were the most commonly reported events [3].

Insulin sensitivity: Riserus et al. (2004) demonstrated in a controlled study that c9,t11-CLA supplementation decreased insulin sensitivity in obese men with metabolic syndrome, accompanied by increased lipid peroxidation and proinflammatory markers [8]. The t10,c12 isomer specifically has been associated with insulin resistance in obese populations [8]. A GRADE-assessed meta-analysis found CLA supplementation increased fasting blood glucose and AST levels [16].

Lipid peroxidation: Basu et al. (2000) found CLA induced lipid peroxidation in men with abdominal obesity [7]. Laboratory studies suggest CLA has both anti- and pro-oxidant effects depending on context, with myocardial oxidative stress potentially occurring through changes in transmembrane potential or the antioxidant defense system [7].

Cardiovascular lipid markers: Leilami et al. (2021) meta-analysis: CLA significantly increased Lp(a) (WMD: 16.68 mg/L), particularly at doses >=3.5 g/day [13]. Wanders et al. (2010): high CLA intake decreased HDL and affected total-to-HDL ratio [7][14].

Hepatotoxicity: Bilal et al. (2015) reported acute hepatitis in a 26-year-old female after CLA supplement use for weight loss, though the supplement may have contained additional ingredients [19].

Neurological events: Eliasson et al. (2018) described severe migraine aura with visual disturbance triggered by CLA supplementation in an older adult male without prior migraine history [20]. Costa et al. (2017) reported reversible cerebral vasoconstriction syndrome in a 50-year-old woman following initiation of a supplement containing CLA, green tea, and L-carnitine [21].

Managing side effect risks across a multi-supplement stack can feel overwhelming, especially when interactions between supplements, medications, and foods add layers of complexity. Doserly brings all of that into a single safety view so nothing falls through the cracks.

Rather than researching every possible interaction yourself, the app checks your full stack automatically and flags supplement-drug and supplement-supplement interactions that warrant attention. If you do experience something unexpected, logging it takes seconds, and over time the app helps you spot patterns: whether symptoms correlate with specific doses, timing, or combinations. One place for the safety picture that matters most when your stack grows beyond a few bottles.

Dosing & Usage Protocols

The Basics

The most commonly studied dose range for CLA is 3,200 to 6,400 mg per day of total CLA product, taken with meals. Because commercial CLA supplements typically contain around 70-80% active isomers by weight, the actual amount of active CLA reaching your system is somewhat less than what the label says [2].

Most research has used a 50:50 mixture of the two main isomers (c9,t11 and t10,c12). The meta-analysis data showing modest fat loss used doses centered around 3.2 g/day of CLA [15]. Studies using higher doses have not consistently shown additional benefits [2].

There is no established loading phase or cycling protocol for CLA. Most trials run for 8 to 12 weeks, with some extending to 12 months. The longest safety data available covers about 12 months of continuous use at standard doses [3].

It is worth noting that the body composition effects of CLA, such as they are, appear to develop gradually. Researchers have not identified a point at which CLA produces a sudden, noticeable change. Rather, any effect accumulates slowly over weeks and months.

The Science

Dose-response data: Supplemental CLA dosing in clinical trials typically ranges from 3.2 to 6.4 g/day, with most positive body composition outcomes observed at the 3.2-3.6 g/day range [2][3][15]. The Blankson et al. (2000) dose-response trial tested 1.7, 3.4, 5.1, and 6.8 g/day CLA in overweight subjects; results showed no clear dose-dependent response, suggesting a relatively flat dose-response curve above the minimum effective threshold [3].

Isomer ratio: Most commercially available CLA supplements provide c9,t11 and t10,c12 in approximately equal proportions (50:50 or 80:20 preparations). The t10,c12 isomer is primarily responsible for body composition effects, while c9,t11 may contribute to anticancer activity [2][7]. No clinical consensus exists on whether isomer-specific supplementation is preferable to mixed-isomer products.

Duration considerations: Body composition trials have ranged from 4 weeks to 24 months, with meta-analytic effects driven primarily by studies of 8-12 weeks duration [4][5]. The one-year trial by Blankson et al. showed sustained but modest fat reduction without progressive dose-response [3].

Form considerations: FFA-form CLA (3.6 g isomers) was compared to TAG-form CLA (3.0 g isomers) in the Blankson et al. trial, with both forms significantly reducing body fat mass, though the different absolute doses complicate direct bioavailability comparisons [3].

When your stack includes several supplements, each with its own dose, form, and timing requirements, the logistics alone can derail consistency. Doserly consolidates all of it into one protocol view, so every dose across your entire routine is accounted for without spreadsheets or guesswork.

The app also tracks cumulative intake for nutrients that appear in multiple products. If your multivitamin, standalone supplement, and fortified protein shake all contain the same nutrient, Doserly adds them up and shows you the total alongside recommended and upper limits. Managing a thoughtful supplement protocol shouldn't require a degree in nutrition science. The app handles the complexity so you can focus on staying consistent.

What to Expect (Timeline)

Weeks 1-2: Most people will not notice any changes. CLA does not produce immediate, perceptible effects. Some may experience mild gastrointestinal adjustment (bloating, loose stools) that typically resolves within the first week. Taking CLA with meals helps reduce digestive discomfort.

Weeks 3-4: Still unlikely to notice measurable changes. CLA isomers are gradually incorporating into cell membranes and tissue lipids. Any body composition effects are accumulating well below the threshold of daily perception.

Weeks 5-8: If CLA is going to produce a measurable effect, this is roughly when it might begin to show up on precise body composition measurements (DEXA scans, skinfold calipers). Based on meta-analysis data, a person might expect roughly 0.5-1 kg of additional fat loss compared to not taking CLA, though this is difficult to separate from normal weight fluctuations. The effect is far too small to see in the mirror or notice on a standard bathroom scale in most cases.

Weeks 8-12: The period covered by most clinical trials. Cumulative fat loss attributable to CLA at 3.2 g/day may reach approximately 1-1.5 kg beyond what diet and exercise alone would produce, based on meta-analytic averages. This is the point at which some trial participants show statistically significant body fat percentage reductions. Individual variation is substantial.

Months 3-12: Long-term data from the Blankson et al. 12-month trial shows that fat loss effects plateau rather than continuing to accumulate linearly. The modest initial benefit is maintained but does not dramatically increase over longer supplementation periods. No significant safety concerns have emerged from 12-month supplementation at standard doses.

Important context: Many users report no noticeable effect at any time point. Community feedback consistently describes CLA's effects as imperceptible without precise measurement tools. People who see visible changes while taking CLA should consider whether concurrent diet, exercise, or other lifestyle changes are the primary drivers.

Interactions & Compatibility

SYNERGISTIC

• Fish Oil (EPA/DHA): Both are fatty acid supplements; CLA and omega-3s may have complementary effects on inflammation pathways, though one anecdotal report notes increased soreness when combining them.
• Calcium: Some animal studies suggest calcium may enhance CLA's effects on body composition, though human data is limited.
• Creatine: No known interaction. Both are commonly used in body composition stacks, though CLA's contribution is minimal compared to creatine's well-documented effects.
• Vitamin E: As an antioxidant, vitamin E may help counteract the lipid peroxidation associated with CLA supplementation.

CAUTION / AVOID

• Diabetes medications (metformin, insulin, sulfonylureas): CLA may increase fasting blood glucose and reduce insulin sensitivity, potentially counteracting diabetes medications. Healthcare provider consultation is essential [8][16].
• Blood thinners / anticoagulants (warfarin, aspirin): CLA affects prostaglandin synthesis and platelet function; theoretical interaction risk with anticoagulant medications.
• Cholesterol-lowering medications (statins): CLA has mixed effects on lipid profiles and may increase lipoprotein(a); monitoring of lipid panels is recommended if combining CLA with statin therapy [13][14].
• Other weight loss supplements: Combining CLA with stimulant-based fat burners, green tea extract, or caffeine supplements may increase the risk of adverse effects. The case of reversible cerebral vasoconstriction syndrome involved CLA combined with green tea and L-carnitine [21].

How to Take / Administration Guide

Recommended forms: The free fatty acid (FFA) form may have slightly better bioavailability than the triacylglycerol (TAG) form based on limited comparative data. Most commercial products use a 50:50 blend of c9,t11 and t10,c12 isomers. Look for products that specify the isomer content on the label rather than just total CLA weight.

Timing considerations: CLA is typically taken with meals, divided into 2-3 doses throughout the day. Taking it with food improves absorption and significantly reduces the risk of gastrointestinal side effects. There is no evidence that timing CLA around exercise provides additional benefit.

Stacking guidance: CLA can be taken alongside most other supplements without known interactions. However, given its modest efficacy, stacking it with multiple other fat loss supplements is unlikely to produce synergistic results and may increase side effect risk. If body composition is the goal, evidence-based options like creatine, adequate protein intake, and consistent resistance training will produce more reliable results.

Cycling guidance: No cycling protocol has been established or studied for CLA. Most trials use continuous supplementation. Given the lack of clear dose-response data beyond 12 months, periodic reassessment of whether CLA supplementation is providing value is reasonable.

Choosing a Quality Product

Third-party certifications: Look for CLA products tested by USP, NSF International, or ConsumerLab.com. NSF Certified for Sport or Informed Sport certification is important for competitive athletes, as it screens for banned substance contamination.

Isomer content and transparency: Quality CLA products will specify the content of c9,t11 and t10,c12 isomers, not just total CLA weight. Products claiming "1,000 mg CLA per softgel" may contain only 700-800 mg of active isomers, with the remainder being other fatty acids and isomers. The most commonly cited commercial formulations are marketed under brand names like Clarinol and Tonalin, which provide standardized isomer ratios.

Source oil: Most CLA supplements are derived from safflower oil or sunflower oil through alkaline isomerization. The source oil itself does not significantly affect the quality of the final CLA product, but some manufacturers may highlight their source as a marketing differentiator.

Red flags:

• Products that do not specify isomer content or ratio
• Proprietary blends that hide the actual CLA dose
• Claims of dramatic fat loss or "melting belly fat" (inconsistent with the evidence base)
• Products combining CLA with stimulants or undisclosed ingredients
• Unusually low-priced products without third-party testing verification

Excipient considerations: CLA softgels typically contain gelatin (bovine or piscine), glycerin, and sometimes caramel coloring. Vegetarian capsule options exist but are less common. Check for common allergens if you have sensitivities.

Storage & Handling

CLA softgels should be stored in a cool, dry place away from direct sunlight and heat. Like all polyunsaturated fatty acid supplements, CLA is susceptible to oxidation when exposed to air, light, or elevated temperatures. Oxidized CLA may develop an off-taste or rancid smell.

Keep the bottle tightly sealed between uses. If CLA capsules develop an unusual odor, become discolored, or the softgels appear to be leaking, discard the product. Refrigeration is not required for softgel capsules but may extend shelf life, particularly in warm climates.

Check the expiration date before purchase and before use. CLA supplements typically have a shelf life of 18-24 months from the date of manufacture when stored properly.

Lifestyle & Supporting Factors

Diet: CLA occurs naturally in dairy products and meat from grass-fed ruminant animals. Grass-fed beef and dairy products contain higher CLA levels than conventionally raised equivalents, with grass-fed butter being a particularly concentrated source. A diet rich in these foods provides the c9,t11 isomer, which is the predominant natural form. Individuals seeking CLA's potential body composition effects should note that dietary CLA (primarily c9,t11) differs from supplemental CLA (mixed c9,t11 and t10,c12), and the body composition effects are attributed mainly to the t10,c12 isomer.

Exercise: CLA does not appear to enhance the benefits of exercise or improve exercise performance based on controlled trials [7][17]. Body composition changes, if any, will be driven primarily by training stimulus and nutritional strategy rather than CLA supplementation. Resistance training combined with adequate protein intake remains the most evidence-based approach to improving body composition.

Body composition monitoring: Given CLA's small effect size, standard bathroom scales are inadequate for detecting CLA-specific changes. Anyone choosing to supplement with CLA for body composition purposes should consider more precise measurement methods such as DEXA scans or multi-site skinfold caliper measurements at regular intervals (4-8 week checks) to determine whether the supplement is producing a measurable response.

Caloric balance: CLA does not override the fundamental relationship between energy intake and energy expenditure. Any body composition effects observed in clinical trials occur in the context of existing dietary patterns and are additive to (not a replacement for) a balanced nutritional approach.

Regulatory Status & Standards

United States (FDA)

CLA is regulated as a dietary supplement under DSHEA. It has received GRAS (Generally Recognized As Safe) status for use as a food ingredient at levels up to 1.5 g/day (as CLA-rich oil). As a dietary supplement, CLA products do not require pre-market FDA approval for efficacy, though manufacturers must comply with current Good Manufacturing Practice (cGMP) regulations. The FDA has issued no specific safety alerts or warning letters regarding CLA supplements.

Canada (Health Canada)

CLA is available as a Natural Health Product (NHP) in Canada. Licensed CLA products carry a Natural Product Number (NPN) and must meet Health Canada monograph requirements for identity, purity, and quality.

European Union (EFSA)

EFSA has evaluated CLA-containing foods and supplements. CLA-rich oils from safflower have been assessed under Novel Food Regulations. EFSA has not authorized specific health claims for CLA related to body composition or weight management, reflecting the overall weak evidence base for these effects.

Australia (TGA)

CLA is available as a complementary medicine under the TGA's Listed Medicines program. Products must meet quality and safety requirements for listing.

Athlete & Sports Regulatory Status

WADA: CLA is not on the World Anti-Doping Agency Prohibited List. It is not a prohibited substance in-competition or out-of-competition.

National Anti-Doping Agencies: No major national anti-doping organizations (USADA, UKAD, Sport Integrity Canada, Sport Integrity Australia, NADA Germany) have issued specific advisories regarding CLA supplementation.

Professional Sports Leagues: CLA is not banned by the NFL, NBA, MLB, NHL, MLS, or NCAA. However, as with all supplements, athletes should ensure their CLA product has been third-party tested for prohibited substance contamination.

NCAA: CLA is not on the NCAA banned substance list. Athletic departments providing supplements to student-athletes are required to use NSF Certified for Sport or Informed Sport certified products.

Athlete Certification Programs: CLA products with Informed Sport (sport.wetestyoutrust.com), NSF Certified for Sport (nsfsport.com), or Cologne List (koelnerliste.com) certification are available. Athletes should verify current product certification before use.

GlobalDRO: Athletes can check CLA product status at GlobalDRO.com for US, UK, Canada, Australia, Japan, Switzerland, and New Zealand.

Regulatory status and prohibited substance classifications change frequently. Athletes should always verify the current status of any supplement with their sport's governing body, their national anti-doping agency, and a qualified sports medicine professional before use. Third-party certification (Informed Sport, NSF Certified for Sport) reduces but does not eliminate the risk of contamination with prohibited substances.

Frequently Asked Questions

Does CLA actually help you lose weight?
Based on available meta-analyses, CLA supplementation at approximately 3.2 g/day produces a statistically significant but very small reduction in body fat, roughly 0.09 kg (0.2 lbs) per week compared to placebo. Multiple research reviews note these effects may not reach clinical significance, and high-quality study subgroups sometimes fail to confirm the effect. Most researchers and community members describe the practical impact as minimal for most individuals.

What is the difference between CLA from food and CLA supplements?
CLA in food (primarily dairy and grass-fed meat) is over 90% the c9,t11 isomer. Supplemental CLA is produced synthetically from safflower or sunflower oil and contains a roughly 50:50 mixture of c9,t11 and t10,c12 isomers. The body composition effects studied in clinical trials are attributed primarily to the t10,c12 isomer, which is present in much lower amounts in food sources.

Is CLA safe for people with diabetes?
Available research raises concerns about CLA supplementation in people with diabetes or metabolic syndrome. One controlled study found CLA decreased insulin sensitivity in obese men at high cardiovascular risk, and a meta-analysis found CLA increased fasting blood glucose levels. Individuals with diabetes or prediabetes should discuss CLA supplementation with their healthcare provider before starting.

Can CLA cause heart problems?
CLA has been associated with potentially unfavorable changes to cardiovascular lipid markers, including increased lipoprotein(a), reduced HDL cholesterol, and altered total-to-HDL cholesterol ratios. These effects are most pronounced at doses of 3.5 g/day or higher and in overweight or obese individuals. People with existing cardiovascular disease or risk factors should consult a healthcare provider.

How long does CLA take to work?
Based on clinical trial data, any measurable body composition effects from CLA typically require at least 8-12 weeks to detect, and even then, the effects are small enough that precise measurement tools (DEXA scan, calipers) are needed to distinguish them from normal weight fluctuations. Most people will not notice subjective differences.

Should I take CLA or fish oil?
CLA and fish oil are different supplements with different evidence profiles. Fish oil (EPA/DHA) has a substantially stronger evidence base for cardiovascular health, inflammation reduction, and overall health benefits. CLA's evidence base is weaker, with smaller and less consistent effects. They are not interchangeable, and fish oil would generally be considered the higher-priority supplement for most health goals.

Is CLA better in free fatty acid or triacylglycerol form?
One clinical trial found the free fatty acid (FFA) form produced marginally greater body fat reduction compared to the triacylglycerol (TAG) form, but the trial compared different absolute doses, complicating direct comparison. The practical difference between forms appears small relative to the already small overall effect of CLA.

Does CLA build muscle?
One meta-analysis found a very small increase in fat-free mass (0.27 kg on average) with CLA supplementation. This is not a meaningful muscle-building effect. CLA should not be considered a muscle-building supplement. Resistance training, adequate protein intake, and evidence-based supplements like creatine are far more effective for muscle growth.

Can I get enough CLA from food alone?
Average dietary CLA intake is estimated at 151-212 mg/day, far below the 3,200 mg/day used in most clinical trials. While grass-fed dairy and meat provide more CLA than conventional products, reaching supplemental doses through food alone is impractical. However, given CLA's modest effect profile, the question of whether supplemental doses are worthwhile is itself debatable.

Does CLA interact with medications?
CLA may interact with diabetes medications (by affecting blood glucose and insulin sensitivity), blood thinners (through effects on prostaglandin synthesis), and cholesterol-lowering medications (through effects on lipid profiles). Anyone taking prescription medications should consult their healthcare provider before adding CLA to their supplement regimen.

Myth vs. Fact

Myth: CLA is a powerful fat burner that can melt away stubborn belly fat.
Fact: Multiple meta-analyses consistently show CLA produces very small reductions in body fat (approximately 0.09 kg per week) that are at the border of clinical significance. High-quality study subgroups have failed to confirm the effect. CLA is not comparable to established fat loss interventions like caloric restriction and exercise [4][5][15].

Myth: CLA works in humans the same way it works in animal studies.
Fact: Animal studies showed dramatic fat loss with CLA, but these results have not translated to humans. The discrepancy is attributed to species differences in PPAR receptor sensitivity, differences in CLA metabolism, and the much higher relative doses used in animal studies. CLA's interaction with human PPAR receptors is substantially weaker than in rodent models [2][6].

Myth: Higher doses of CLA produce better results.
Fact: The dose-response relationship for CLA appears flat above approximately 3.2 g/day. The Blankson et al. trial tested doses from 1.7 to 6.8 g/day and found no dose-dependent response in body composition outcomes. Higher doses do not predictably lead to greater fat loss [2][3].

Myth: CLA is completely safe with no side effects.
Fact: While CLA is generally well-tolerated, it has documented adverse effects including gastrointestinal symptoms, potential insulin resistance in metabolically compromised individuals, increased lipoprotein(a) levels, decreased HDL cholesterol, and rare but serious case reports including hepatitis and migraine aura [7][8][13].

Myth: Natural CLA from food and supplemental CLA are the same thing.
Fact: Dietary CLA (from dairy and meat) is predominantly the c9,t11 isomer (over 90%), while commercial CLA supplements provide a roughly 50:50 mix of c9,t11 and t10,c12 isomers. The body composition effects studied in trials are primarily attributed to the t10,c12 isomer. The two forms have different isomer profiles and potentially different biological effects [1][2].

Myth: CLA improves exercise performance and helps build muscle.
Fact: Controlled trials found CLA had no effect on aerobic capacity, neuromuscular fatigue, or exercise performance. A study in experienced resistance-trained athletes found no significant effects on body mass, fat-free mass, fat mass, strength, or general markers of catabolism. CLA does not function as an ergogenic aid [7][17].

Myth: CLA is anti-inflammatory.
Fact: CLA has a dual inflammatory profile. Meta-analyses show it decreases some inflammatory markers (TNF-alpha, IL-6) while increasing others (C-reactive protein). Characterizing CLA as simply "anti-inflammatory" is an oversimplification of a more complex and contradictory picture [10][11].

Sources & References

Systematic Reviews & Meta-Analyses

[1] NIH Office of Dietary Supplements. "Perspectives on Conjugated Linoleic Acid Research: Current Status and Future Directions." NIH Conference Proceedings, 2002. https://ods.od.nih.gov/pubs/conferences/cla/clasummary.html

[2] Pariza MW, Park Y, Cook ME. Mechanisms of action of conjugated linoleic acid: evidence and speculation. Proc Soc Exp Biol Med. 2000;223:8-13. See also: Belury MA. Conjugated dienoic linoleate: a polyunsaturated fatty acid with unique chemoprotective properties. Nutr Rev. 1995;53:83-9.

[3] NIH Office of Dietary Supplements. "Dietary Supplements for Weight Loss: Fact Sheet for Health Professionals." Updated May 2022. https://ods.od.nih.gov/factsheets/WeightLoss-HealthProfessional/ — References: Blankson H, Stakkestad JA, Fagertun H, et al. Conjugated linoleic acid reduces body fat mass in overweight and obese humans. J Nutr. 2000;130:2943-8.

[4] Asbaghi O, Shimi G, Hosseini Oskouie F, et al. The effects of conjugated linoleic acid supplementation on anthropometrics and body composition indices in adults: A systematic review and dose-response meta-analysis. Br J Nutr. 2023;130(7). https://doi.org/10.1017/S0007114523001988

[5] Esmaeilnejad M, et al. The effects of conjugated linoleic acid supplementation on cardiovascular risk factors in patients at risk of cardiovascular disease: A GRADE-assessed systematic review and dose-response meta-analysis. Br J Nutr. 2024;132(7):919-934. https://pubmed.ncbi.nlm.nih.gov/39439191/

[6] Putera HD, Doewes RI, Shalaby MN, et al. The effect of conjugated linoleic acids on inflammation, oxidative stress, body composition and physical performance: a comprehensive review of putative molecular mechanisms. Nutr Metab. 2023;20:35. https://doi.org/10.1186/s12986-023-00758-9

Clinical Trials & Observational Studies

[7] Memorial Sloan Kettering Cancer Center. "Conjugated Linoleic Acid." About Herbs Database. Updated November 2023. https://www.mskcc.org/cancer-care/integrative-medicine/herbs/conjugated-linoleic-acid — Compiled references for clinical trial data.

[8] Riserus U, Vessby B, Arnlov J, et al. Effects of cis-9,trans-11 conjugated linoleic acid supplementation on insulin sensitivity, lipid peroxidation, and proinflammatory markers in obese men. Am J Clin Nutr. 2004;80(2):279-283.

[9] Tsao JP, Liao SF, Korivi M, et al. Oral conjugated linoleic acid supplementation enhanced glycogen resynthesis in exercised human skeletal muscle. J Sports Sci. 2015;33(9):915-923.

[10] Rastgoo S, Shimi G, Shiraseb F, et al. The effects of conjugated linoleic acid supplementation on inflammatory cytokines and adipokines in adults: A GRADE-assessed systematic review and dose-response meta-analysis. Front Immunol. 2023;14:1092077. https://pubmed.ncbi.nlm.nih.gov/36911696/

[11] Haghighatdoost F, Nobakht MGBF. Effect of conjugated linoleic acid on blood inflammatory markers: a systematic review and meta-analysis on randomized controlled trials. Eur J Clin Nutr. 2018;72(8):1071-1082.

[12] Herbel BK, McGuire MK, McGuire MA, Shultz TD. Safflower oil consumption does not increase plasma conjugated linoleic acid concentrations in humans. Am J Clin Nutr. 1998;67:332-7.

[13] Leilami K, Kohansal A, Mohammadi Sartang M, et al. Adverse effects of conjugated linoleic acids supplementation on circulating lipoprotein (a) levels in overweight and obese individuals: results of a systematic review and meta-analysis of randomized controlled trials. Am J Cardiovasc Dis. 2021;11(1):124-135. https://ncbi.nlm.nih.gov/pmc/articles/PMC8012289/

[14] Wanders AJ, Brouwer IA, Siebelink E, et al. Effect of a high intake of conjugated linoleic acid on lipoprotein levels in healthy human subjects. PLoS One. 2010;5(2):e9000.

[15] Whigham LD, Watras AC, Schoeller DA. Efficacy of conjugated linoleic acid for reducing fat mass: a meta-analysis in humans. Am J Clin Nutr. 2007;85:1203-1211.

Government/Institutional Sources

[16] Esmaeilnejad M, et al. The effects of conjugated linoleic acid supplementation on glycemic control, adipokines, cytokines, malondialdehyde and liver function enzymes in patients at risk of cardiovascular disease: a GRADE-assessed systematic review and dose-response meta-analysis. Nutr J. 2023;22:47. https://doi.org/10.1186/s12937-023-00876-3

[17] Tajmanesh M, Aryaeian N, Hosseini M, et al. Conjugated Linoleic Acid Supplementation has no Impact on Aerobic Capacity of Healthy Young Men. Lipids. 2015;50(8):805-809.

Case Reports

[18] MacRedmond R, Singhera G, Attridge S, et al. Conjugated linoleic acid improves airway hyper-reactivity in overweight mild asthmatics. Clin Exp Allergy. 2010;40(7):1071-8.

[19] Bilal M, Patel Y, Burkitt M, Babich M. Linoleic Acid Induced Acute Hepatitis: A Case Report and Review of the Literature. Case Reports Hepatol. 2015;2015:807354.

[20] Eliasson JH, Birgisdottir BE, Gudmundsson LS. A Case of Complete Scotoma Following Intake of Conjugated Linoleic Acid Supplement. Headache. 2018;58(5):761-763.

[21] Costa I, Mendonca MD, Cruz ESV, et al. Herbal Supplements Association with Reversible Cerebral Vasoconstriction Syndrome: A Case Report. J Stroke Cerebrovasc Dis. 2017;26(3):673-676.

Related Supplement Guides

Same Category

• Fish Oil (EPA/DHA) — Fellow fatty acid supplement with a substantially stronger evidence base for cardiovascular and anti-inflammatory effects
• Algal Oil — Vegan omega-3 source
• Krill Oil — Alternative omega-3 source with phospholipid delivery

Common Stacks / Pairings

• L-Carnitine — Often combined in body composition stacks (note: one adverse event case report involved CLA + L-carnitine + green tea)
• Green Tea Extract — Frequently paired for fat loss goals
• Caffeine — Common stimulant in fat loss stacks
• Creatine — Evidence-based body composition supplement
• Whey Protein — Foundation supplement for body composition

Related Health Goal

• Chromium — Glucose metabolism and body composition
• Alpha-Lipoic Acid — Antioxidant with metabolic effects
• Garcinia Cambogia — Another weight loss supplement with modest evidence
• Calcium — May interact with CLA for body composition effects
• Vitamin E — Antioxidant that may counteract CLA-induced lipid peroxidation